Clinical Trials Directory

Trials / Completed

CompletedNCT02321553

Effect of Brown Rice on the Risk Factors for Metabolic Syndrome

Biological Functions of Brown Rice on Metabolic Syndrome: A Randomized Cross-over Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Tufts University · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine the effect of consumption of brown rice on the risk factors of metabolic syndrome (MetS) as compared to consumption of white rice. Brown and white rice will be provided in the form of rice cakes and 100g will be consumed per day for 5 weeks each. The investigators hypothesize that brown rice will have beneficial effects as it is rich in fiber and also phytochemicals.

Detailed description

This is a 2-way cross-over, randomized, placebo controlled, pilot feasibility study to determine the effect of brown rice on the risk factors of metabolic syndrome (MetS). Eligible subjects (n = 9) with the MetS (\>50 yr, post-menopausal women and men) will be randomized to receive either brown rice cakes (100 g/d) as treatment or white rice cake as placebo during each 5-wk intervention phase with a 2-wk washout between phases. Subjects will visit Tufts Medical Center for all study visits, at the end of baseline (first 2 week run in phase) and weeks 7, 9 and 14, which will include a 12 hour fasting blood draw. Two sets of three 24 hour dietary recalls will be conducted during the intervention phases. Fasting blood samples will be analyzed for 1) oxidative stress markers (vitamin E concentrations, total antioxidant capacity, and lipid peroxidation product), 2) blood lipid profiles and 3) metabolic risk factors such as plasma glucose, insulin, inflammatory cytokines.

Conditions

Interventions

TypeNameDescription
OTHERBrown ricebrown rice cake
OTHERWhite ricewhite rice cake

Timeline

Start date
2014-04-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2014-12-22
Last updated
2015-05-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02321553. Inclusion in this directory is not an endorsement.